Evidence map›Paper›PMID 27007437›Full record

ArticlePloS one2016

Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3.

Richard B Pouw, Mieke C Brouwer, Judy Geissler, Laurens V van Herpen, Sacha S Zeerleder, Walter A Wuillemin, Diana Wouters, Taco W Kuijpers

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of factor H-related protein 3 inFrontiers in immunology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Complement Factor H Levels Associate WithOpen forum infectious diseases · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Richard B PouwDepartment of Immunopathology, Sanquin Research and Landsteiner laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Mieke C BrouwerDepartment of Immunopathology, Sanquin Research and Landsteiner laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Judy GeisslerDepartment of Blood Cell Research, Sanquin Research and Landsteiner Laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Laurens V van HerpenDepartment of Immunopathology, Sanquin Research and Landsteiner laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Sacha S ZeerlederDepartment of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Walter A WuilleminDivision of Hematology and Central Hematology Laboratory, Luzerner Kantonsspital and University of Berne, Berne, Switzerland.
Diana WoutersDepartment of Immunopathology, Sanquin Research and Landsteiner laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Taco W KuijpersDepartment of Pediatric Hematology, Immunology & Infectious Diseases, Emma Children's Hospital, Academic Medical Center, Amsterdam, the Netherlands.
University of Amsterdam · NLSanquin · NLAcademic Medical Center · NLUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The major human complement regulator in blood, complement factor H (FH), has several closely related proteins, called FH-related (FHR) proteins. As all FHRs lack relevant complement regulatory activity, their physiological role is not well understood. FHR protein 3 (FHR-3) has been suggested to compete with FH for binding to Neisseria meningitidis, thereby affecting complement-mediated clearance. Clearly, the in vivo outcome of such competition greatly depends on the FH and FHR-3 concentrations. While FH levels have been established, accurate FHR-3 levels were never unequivocally reported to date. Moreover, CFHR3 gene copy numbers commonly vary, which may impact the FHR-3 concentration. Hence, we generated five anti-FHR-3 mAbs to specifically measure FHR-3 in human healthy donors of which we determined the gene copy number variation at the CFH/CFHR locus. Finally, we examined the acute-phase response characteristics of FHR-3 in a small sepsis cohort. We determined FHR-3 levels to have a mean of 19 nM and that under normal conditions the copy number of CFHR3 correlates to a very large extent with the FHR-3 serum levels. On average, FHR-3 was 132-fold lower compared to the FH concentration in the same serum samples and FHR-3 did not behave as a major acute phase response protein.

Indexed as

Acute-Phase ReactionAntibodies, MonoclonalBlood ProteinsComplement Factor HCross ReactionsDNA Copy Number VariationsEnzyme-Linked Immunosorbent AssayHumansSepsisAntibodies, MonoclonalBlood ProteinsCFHR3 protein, humanComplement Factor H

Identifiers

PMID27007437
PMCPMC4805260
OpenAlexW2308722036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.